Delivery Order SPE2DE24DA010-SPE2D625F3BEN
- Not listed
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $25,715.85 by the Defense Logistics Agency's Medical Supply Chain on August 12, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as GALLANT (4569142750), will be performed in Santa Clara, California, and represents a non-set-aside award made through full and open competition. Abbott Vascular specializes in advanced cardiovascular medical...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract (No. 4569147994, titled "GALLANT") by the Department of Defense Medical Supply Chain on August 19, 2025, with a ceiling value of $38,345.80. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 22, 2025, and will be performed in Santa Clara, California. The contract was awarded without set-aside designation, indicating full...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order (Contract No. 4568634478, GALLANT) by the Medical Supply Chain division of the Department of Defense on June 20, 2025, with an ultimate completion date of June 25, 2025. The contract, valued at $30,281.95, carries no set-aside designation, indicating full and open competition. Performance will occur at Abbott's facility in Santa Clara, California. This delivery order represents a...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $51.3K by the Medical Supply Chain, a defense-focused federal agency, on July 16, 2025. This fixed-price delivery order with economic price adjustment carries an ultimate completion date of July 21, 2025, and will be performed in Santa Clara, California. The contract was awarded under full and open competition with no set-aside designation, indicating Abbott competed against other...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a delivery order contract valued at $1,120.00 by the Medical Supply Chain division of the Department of Defense on September 4, 2025, with an ultimate completion date of September 9, 2025. This fixed-price contract with economic price adjustment authority will be performed in Santa Clara, California. The award represents a continuation of Abbott's extensive role as a critical supplier of advanced cardiovascular...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $28,350.00 by the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, with an ultimate completion date of August 21, 2025. The contract, identified as AVEIR (a reference to Abbott's Aveir Leadless Pacemaker technology), will be performed in Santa Clara, California, and was awarded without a set-aside designation, indicating full and open competition. This...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, has been awarded a fixed-price delivery order with economic price adjustment totaling $9,500 by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as AVEIR and issued on July 29, 2025, with an ultimate completion date of August 1, 2025, will be performed in Santa Clara, California. This delivery order was awarded without set-aside designation, indicating full and open competition among...
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $66,000 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025, with an ultimate completion date of August 5, 2025. The contract, designated as MITRCLIP and issued without set-aside provisions under full and open competition, calls for delivery to Santa Clara, California. This delivery order represents a task order against Abbott's broader federal contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a major pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The $30,281.95 fixed-price delivery order contract has an ultimate completion date of November 26, 2024. The contract does not include a set-aside designation, indicating full and open competition. Abbott Laboratories Inc., through its Abbott Vascular Inc....
- Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order valued at $24,350.00 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025, with an ultimate completion date of September 15, 2025. The contract, which involves no set-aside designation and therefore represents full and open competition, is for the delivery of the Aveir Leadless Pacemaker system to be performed at the contractor's facility in Santa Clara,...
- SPE2DE24DA010Indefinite Delivery Contract
- SPE2DE24DA010-SPE2D625F3BENDelivery Order
Abbott Laboratories Inc., through its Abbott Vascular Inc. division, was awarded a fixed-price delivery order with economic price adjustment valued at $36,320.80 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025. This delivery order, designated as GALLANT (Contract Number 4569403310), was issued without set-aside provisions, indicating full and open competition. The contract will be performed in Santa Clara, California, with an ultimate completion date of September 15, 2025. As a child entity of Abbott Laboratories Inc., Abbott Vascular Inc. continues the parent company's established role as a critical supplier of advanced cardiovascular medical technologies to federal defense and healthcare agencies. This delivery order represents another task order under Abbott's extensive federal contract portfolio with the Defense Logistics Agency, consistent with the company's strategic positioning as a primary provider of sophisticated cardiovascular devices and medical technologies to federal healthcare systems. Abbott Vascular Inc.'s significant Indefinite Delivery Contract with the DLA valued at $117.1 million for comprehensive procedural packages covering cardiovascular technologies, devices, instrumentation, and accessories provides the framework within which this delivery order was issued. The award underscores Abbott's continued importance in supporting federal medical supply chain operations and the company's capability to deliver specialized medical devices and related services to support complex medical procedures across federal healthcare facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $36.3k | 9/10/25 |